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THE VOICE AND CYSTIC FIBROSIS: A DESCRIPTIVE CASE STUDY
VERONICA R. SMITLEY
ABSTRACT
Cystic fibrosis is a common autosomal recessive disease with severe effects on
the respiratory, digestive, and endocrine systems. Symptoms include chronic cough and
wheezing, frequent upper respiratory tract infections, and reflux disease. While most
treatments for cystic fibrosis aim to mitigate the respiratory and gastrointestinal
dysfunction, the potential adverse effects on an individual’s voice has not been
researched in a systematic manner. We hypothesized that individuals with cystic fibrosis
may show physical signs of vocal fold damage, as well as common dysphonic symptoms.
Given the impact voice disorders have an overall quality of life, identification and
management of cystic fibrosis-related dysphonia could be of great importance for
assessment and treatment of this chronic illness. Four individuals participated, a male and
female with cystic fibrosis, and male and female without cystic fibrosis. Each participant
underwent videostroboscopy for vocal fold observation. Additionally, aerodynamic vocal
parameters were measured using the Visi-PitchTM. Substantial structural changes were
observed in the participants with cystic fibrosis. Significant differences in aerodynamic
measures were also found, particularly in the area of vocal perturbation (jitter and
shimmer). Participants with cystic fibrosis had markedly higher measures of jitter and
shimmer. The observed differences may be a direct result of the phonotrauma
experienced during day-to-day treatments and respiratory symptoms of the individual
with cystic fibrosis.
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CHAPTER I
INTRODUCTION
Cystic fibrosis (CF) is a recessive genetic disease that affects approximately
30,000 individuals living in the United States, and 70,000 worldwide (Cystic Fibrosis
Foundation, 2015). The defective gene causes the cystic fibrosis transmembrane
conductance regulator (CFTR) protein in the body’s cells to function poorly. The CFTR
protein functions as a channel for the movement of chloride ions in and out of cells,
which is important for the salt and water balance on epithelial surfaces, such as in the
lungs or pancreas. Malfunctioning of this protein results in a build-up of thick, sticky
mucus throughout the body. According to the Cystic Fibrosis Foundation (2015), there
are over 1,800 different gene mutations, causing a wide variety of symptoms and
severities. The most common symptoms include salty-tasting skin, persistent coughing,
frequent lung infections including pneumonia or bronchitis, wheezing or shortness of
breath, and poor growth or weight gain in spite of a good appetite. With the build-up of
mucus, patients typically suffer respiratory complications. Due to the complexity and
variations of the cystic fibrosis genotypes, most common treatments for patients with CF
are designed for treating these respiratory components. However, it is known that
respiratory dysfunction and persistent coughing can lead to significant trauma to an
individual’s vocal folds, therefore impacting overall vocal quality. The possibility of
vocal fold damage or laryngeal dysfunction has not been thoroughly researched in CF.
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In addition to respiratory distress, individuals with cystic fibrosis often suffer
from various types of gastrointestinal disorders. Due to pancreatic insufficiency, patients
with CF suffer from digestive tract dysfunction, which in turn can lead to acid reflux
diseases such as gastroesophageal reflux disease (GERD) and laryngopharyngeal reflux
disease (LPRD). According to Boone et al. (2014), GERD is defined as the passage of
acid from the stomach back into the esophagus, and LPRD is the passage of acid from the
stomach into the esophagus and superiorly into the larynx. Further research from Boone
et al. (2014) showed that reflux diseases such as these can often compromise the
individual’s vocal folds and affect their ability to function properly.
A study conducted by Rozmanic, Dorian Tjesic-Drinkovic, Banac, Ahel, Duska
Tjesic-Drinkovic, Persic, and Votava-Raic (2009) examined the presence of
gartroesophageal reflux in patients with cystic fibrosis. Rozmanic et al. recruited twentyfive children with CF to undergo 24-hour esophageal pH monitoring. In their study,
Rozmanic et al. (2009) defined an episode of acid reflux as an abrupt fall in
intraesophageal pH less than 4 for at least 15 seconds. Standard variables used included
the reflux index, which was the percentage of times when pH was less than 4, number of
reflux episodes, and the number of reflux episodes lasting longer than 5 minutes.
Rozmanic et al. considered a reflux index of >10% in patients under one year of age to by
pathological, however an RI of >5% was considered pathological for other age groups.
The study revealed that thirteen of the twenty-five patients showed pathological
gastroesophageal reflux (Rozmanic et al., 2009). This study found that the prevalence of
GERD increases with decreased lung function in the individual with CF. Lower lung
function typically results in exacerbation of respiratory symptoms, which in turn leads to
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extra treatments for the patient. All of these factors – severe acid reflux, excess cough,
and extra treatments – can lead to damage of the laryngeal tissue.
The larynx has three main roles in daily living: biological, emotional, and
linguistic. Biologically, the larynx protects the airway from foreign substances during
eating and drinking. Emotionally, the larynx can offer changes in one’s voice to signal
happiness, sadness, anger, etc. In a linguistic function, the larynx offers movement in
order to add various prosodic features to a person’s voice. In other words, movement of
the larynx accounts for vocal stress, pitch and volume changes, as well as respiratory
regulation while speaking and eating. According to Boone, McFarland, Von Berg, and
Zraick (2014), there are five aspects of voice that determine dysfunctionality. These are
(1) loudness (volume of speaker’s voice), (2) hygienic production (whether or not a
speaker’s voice sounds “healthy”), (3) pleasantness (smooth and easy or broken and
harsh), (4) flexibility (ability to use appropriate intonation), and (5) representative (does
the voice fit the speaker, such as man vs. woman). If a person’s voice violates any one or
more of these five aspects, a voice disorder exists.
According to Verdolini and Ramig (1998), voice disorders are generally
characterized by an abnormal functioning in the mechanisms that control pitch, loudness,
and/or vocal quality; that is, the larynx, respiratory system, and/or the vocal tract. Voice
disorders can be considered of functional, organic, or neurogenic etiology. For the
purpose of this study, the focus will be on voice disorders with a functional etiology.
Functional voice disorders are those caused by phonotrauma, or an individual misusing,
or abusing his or her voice. Examples of vocal abuse include screaming, continuously
speaking at a high pitch, persistent throat clearing, or excessive coughing. Often times,
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functional voice disorders can lead to physical damage of the vocal folds. Damage may
occur in the form of benign lesions that grow forth from the tissue of the vocal folds.
These lesions are typically classified into one of four descriptive categories: polyps,
nodules, Reinke’s edema, or cysts. See Figure 1.1 (Cipriani, 2011). As these injuries heal,
they may result in a build-up of scar tissue and ultimately affect the function of the vocal
folds.

Figure 1.1 Benign lesions of the vocal folds. Variations of focal fold lesions due to
phonotrauma. A: Polyps – unilateral, sessile, or pedunculated lesions of the anterior third of
the vocal fold; blister-like appearance. B: Nodules – bilateral, symmetric swellings of the
anterior to middle vocal fold; callus-like appearance. C: Reinke’s edema – unilateral or
bilateral swelling of the entire vocal fold. D: Cyst – discrete unilateral swellings clinically
similar to foregoing 3 lesions. (Cipriani, 2011)

Paradoxical adduction of the vocal folds is another functional vocal fold disorder
that may occur in CF patients. According to the American Speech-language and Hearing
Association (ASHA) (2015), paradoxical vocal fold movement is when the vocal folds
behave in a normal fashion almost all of the time (Figure 1.2), but inappropriately close
during inhalation (Figure 1.3). A case study conducted by Shiels, Hayes, and Fitzgerald
(1995) examined possible causes of this functional disorder. These authors studied a 17year old female diagnosed with cystic fibrosis at birth. At 16 years of age, the girl had
developed prominent hoarseness and noisy sounds in her throat. Upon observation, it was
4

also noted that she had considerable inspiratory stridor with minimal expiratory wheeze.
While her lung functions appeared to be within functional limits, significant upper airway
obstruction during inhalation was seen in interpretation of the flow-volume loop.
Considerable paradoxical adduction of the vocal cords was found on bronchoscopy. The
case study did not determine precisely what was causing this rare disorder, but the
researchers concluded that the diagnosis of paradoxical vocal cord adduction should be
considered in patients with cystic fibrosis and suggested that appropriate physiological
and endoscopic assessments are needed in the general examination of individuals with CF
(Shiels et al., 1995).

Figure 1.2 Normal abduction. Expected
behavior of vocal folds during breathing
(Galek, 2015)

Figure 1.3 Paradoxical adduction.
Improper closure during inhalation
(ASHA, 2014)

Lourenco, Costa, and Filho (2014) investigated aerodynamic measures in
Brazilian individuals with cystic fibrosis. The study compared a female and male control
group to a female and male test group using quantitative vocal parameters as well as
subjective measures.
The quantitative parameters used were fundamental frequency (Fo), jitter,
shimmer, and the harmonics to noise ratio (HNR). Fundamental frequency is defined as
5

the average rate at which an individual’s vocal folds typically vibrate. It is measured by
the number of vibratory cycles the vocal folds complete per second. Fo can also be
termed as a person’s habitual pitch, the pitch that his or her voice has in a typical
everyday setting. Jitter and shimmer are types of vocal perturbation, or variability in the
output of voice. Jitter is the cycle-to-cycle variations of pitch that occur naturally. It often
correlates with perceived vocal roughness. Shimmer is the index of variability in vocal
intensity and is often measured both in decibels (dB) and percentages. When the mean
shimmer is displayed in dB, it indicates the difference between sequential vocal
amplitudes measured during sustained phonation. Mean shimmer in percent is the
absolute cycle-to-cycle difference in amplitude and divided by the mean amplitude then
multiplied by 100 in order to produce a percentage. Last, HNR is an index of glottal
turbulence and noise.
In addition to the aforementioned quantitative measures, Lorenco et al. (2014)
used subjective measurements to analyze the subjects. Each participant was rated on a
perceptual scale called the GRBAS (Grade, Roughness, Breathiness, Asthenia, Strain).
The GRBAS is an assessment method used to evaluate the patients overall grade (G) of
dysphonia through four subjective parameters – roughness, breathiness, asthenia, strain.
Each of these four parameters is then rated as one (mild), two (mild alteration), or three
(severe alteration) (Lorenco et al., 2014).
Lorenco et al. (2014) found that individuals with cystic fibrosis showed
significant differences of vocal quality in the following quantitative factors: decrease in
intensity, increase in jitter and shimmer, and a considerably lower HNR. In addition, the
CF participants showed clear signs of vocal dysfunction in the GRBAS perceptual rating.
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The GRBAS findings showed an overall increase in roughness, breathiness, and asthenia,
as well as an increase in the general grade of dysphonia. The findings showed no
significant differences in strain, according to the GRBAS rating (Lorenco et al., 2014).
Lorenco et al.’s (2014) study serves a guide for the current research. While the
findings were considerable, some gaps and limitations exist that will be examined in the
current study. Many voice specialists believe that the root of a voice disorder can be
found in a visual examination of the vocal folds. In addition, physical examination will
confirm the absence or presence of paradoxical adduction of the vocal folds. Physical
damage caused by vocal abuse may include polyps or nodules and may lead to significant
scar tissue. As previously stated, this type of damage may greatly alter an individual’s
vocal fold function. Visual examination of the vocal folds will also allow for observation
of the mucosal wave. The mucosal wave is the movement of the mucous membrane of
the vocal fold during phonation (Boone et al., 2014). Abnormalities or complete absence
of the mucosal wave is significant in determining the presence of vocal fold pathology
and a possible voice disorder. The hope is that physical examination of the vocal folds in
conjunction with aerodynamic and perceptual measures may give a deeper explanation
behind voice dysfunction in cystic fibrosis.
The present study will aim to extend the findings of Lorenco et al. (2014) by
adding the components of vocal fold visualization and other aerodynamic measures such
as S/Z ratio and maximum phonation time (MPT). The S/Z ratio measurement is a fairly
simple procedure which measures the length of time a person can sustain the “s” sound
and the length of time they can sustain the “z” sound, then divides the two figures to
obtain a numerical ratio. The higher the figure the greater the possibility that the person is
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experiencing difficulty with phonation. It is widely accepted in speech science that an S/Z
ratio greater than 1.4 is indicative of laryngeal insufficiency; greater than 2.0 is
considered symptomatic of vocal fold pathology and should be further assessed (Boone et
al., 2014). This parameter is not typically used as a diagnostic tool by itself, but it may be
used to determine the possibility of laryngeal malfunction.
MPT is the maximum time (in seconds) for which a person can sustain a vowel
sound when produced on one deep breath at a relatively comfortable pitch and loudness.
Similar to the S/Z ratio, this is a quick and simple aerodynamic measure. Typically, with
no laryngeal pathology, adult males can sustain vowel sounds for between 25-35 seconds
and adult females between 15-25 seconds. As with the S/Z ratio, MPT is not diagnostic of
laryngeal pathology, but it may be a precursor to vocal fold dysfunction. Research has
shown that many voice disorders may stem from lack of respiration needed in order to
produce voice. These parameters will give a better understanding of the individual’s
respiratory abilities as they relate to voice production.
Individuals living with CF may benefit from a confirmed diagnosis of voice
disorder and a subsequent plan for voice therapy in order to further improve their quality
of life. The purpose of this study is to further investigate through both perceptual and
objective measures the presence of vocal fold dysfunction in individuals with cystic
fibrosis.
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CHAPTER II
METHODS
Participant Selection and Ethics Statement
The investigation, materials, and procedures for this study were approved by the
Institutional Review Board (IRB) of Cleveland State University. Participants were
recruited from the community by word of mouth through the student investigator who
verbally contacted individuals with the diagnosis of cystic fibrosis and who are members
of her support group. A total of four individuals participated in this study, one male and
one female with a diagnosis of cystic fibrosis, and one male and female without cystic
fibrosis. All participants reported that they have never been previously diagnosed with a
vocal fold disorder and had never received voice therapy. There were no financial
incentives for participation.
The participants with CF were diagnosed within the first year of life using the
traditional sweat test and presence of pancreatic insufficiency. They were also diagnosed
with Cystic Fibrosis-Related Diabetes (CFRD) and placed on an insulin regimen. They
were receiving individual, regular treatment from a team of medical professionals,
including

physician,

pulmonology,

dietician,

respiratory

therapist,

ENT,

and

endocrinologist. At the time of data collection, the participants were not experiencing an
exacerbation of CF symptoms.
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Consent Form
The investigator recruited, screened, and collected data for all participants. All
data were collected in the voice lab of the Cleveland State University Speech and Hearing
Clinic. All participants agreed and signed the consent form after discussing all procedures
and associated risks with the examiner. Participants were also offered a reference copy of
the consent form.
Objective Vocal Analysis
The following quantitative measures were collected on each participant using the
KayPentax Visi-PitchTM IV, model number 3950B: fundamental frequency, jitter, relative
average perturbation (RAP), shimmer (measured in dB and percentages), and noise-toharmonic (NHR) ratio. The Visi-PitchTM is a computerized device that measures and
stores vocal information. For this study, the participants were instructed (Appendix A) to
phonate into a free-standing microphone attached to the machine. The microphone was
positioned approximately two inches from each participant's mouth. The abovementioned parameters have been extensively researched and validated as adequate
objective measures for vocal quality. They are routinely used by specialists in the field as
diagnostic tools. Abnormalities within these parameters are potential signs of dysphonia
(Lorenco et al., 2014).
S/Z ratio and maximum phonation time were collected by the student investigator.
To collect S/Z ratio, the patient was instructed to produce the “s” sound for as long as
possible while they were timed. Next, the patient was instructed to produce the “z” sound
for as long as possible. The investigator then divided the “s” time by the “z” time to
calculate the ratio. Three trials were completed, and the lowest ratio reported for analysis.

10

To measure MPT, the investigator instructed the patient to produce the open vowel “ah”
for as long as possible while being timed. The timer was stopped and time recorded when
the patient’s voice began to waiver. Again, three trials were completed and the best time
reported for analysis.
Videostroboscopy
KayPentax Rhino-Laryngeal StroboscopeTM model RLS 9100B was used to
conduct videostroboscopy in order to complete a visual examination of the vocal folds.
Videostroboscopy is a routine procedure used by ENTs and speech-language pathologists
as a tool for assessment of vocal fold damage or dysfunction. A rigid endoscope attached
to a camera from the videostroboscopy instrument was placed at the base of the tongue in
the oral cavity while the participant was instructed to vocalize the open vowel /ah/. The
investigator directly observed the participants’ laryngeal structures, as well as the vocal
fold mucosal wave.
Subjective Vocal Analysis
In addition to the objective measures, each participant, with the investigator,
completed a self-assessment of his or her own vocal quality. A perceptual assessment of
vocal quality in CF participants was obtained using the Clinical Voice Evaluation 2
(CVE2)

(2003),

a paper and pencil self-assessment. The participant evaluated eight

parameters of his or her own voice: quality, pitch, pitch range, loudness, nasal resonance,
oral resonance, rate, and prosody. The ratings were based on a scale of 0 to 3: 0 = normal,
1 = mild, 2 = moderate, 3 = severe. The participant then provided a self-perception rating
of his or her voice using the same rating scale. Professionals do not necessarily use this
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particular self-assessment as a diagnostic tool, rather as a screening tool to determine the
need for further voice evaluation.
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CHAPTER III
RESULTS
Videostroboscopy
Female vocal folds. Still images from the videostroboscopy demonstrating
abduction and adduction of the vocal folds in female participants are shown in Figure 3.1.
In comparing the laryngeal structures of the female with CF to the same-age, non-CF
participant, some significant structural differences were observed. The first noted
difference is in the arytenoid cartilages, the structures that lie directly anterior to the
vocal folds. As seen in the non-CF female participant (Figure 3.1A), the arytenoid
cartilages are structures that have defined structural characteristics; this is to be expected.
Upon examination of the female CF subject (Figure 3.1B), significant inflammation,
swelling, and thickening of the tissue was noted to exist to the point where the arytenoid
cartilages do not stand out as individual, distinct structures. Instead, these structures
merely blend into the surrounding laryngeal tissue.
The second most notable difference was seen during adduction of the vocal folds.
Typically, when adducted, the vocal folds come together and form a complete closure of
the glottal space (Figure 3.1C). In the participant with CF (Figure 3.1D), incomplete
glottal closure was noted upon adduction. The small opening, also called a posterior
glottal “chink,” is not uncommon in females. In Figure 3.1D, the interarytenoid edema
13

was made even more obvious as the space that should exist between the arytenoid
cartilages was significantly diminished.
In addition to the incomplete glottal closure, it was noted that the vocal folds of
the female patient with CF are substantially thicker than the non-CF female. The vocal
folds were not as elongated compared to those of the female without CF.
In reviewing the videostroboscopy, vocal fold movement was considered
functional for the female patient with CF. The mucosal wave for this patient was
observed to be slower than that of the female without CF. Furthermore, there was
abnormal movement of the arytenoid cartilages and false vocal folds. Typically, these
structures move slightly toward midline upon phonation, but do not move together
completely as the vocal folds do. For the patient with CF, the arytenoid cartilages
complete vibratory cycles in a near-spastic manner. This anomaly does not occur
regularly, but rather at random intervals.
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A

B

C

D

Figure 3.1. Vocal folds of female participants. Shown in abducted and adducted
position. A: Abducted vocal folds of female without CF. B: Abducted vocal folds of
female with CF, notice the swollen arytenoids. C: Adducted vocal folds of female
without CF. D: Adducted vocal folds of female with CF; note the thickness of the
vocal folds as well as incomplete glottal closure.
Male vocal folds. Figure 3.2 shows comparative images of the vocal folds of the
male participants, both CF and non-CF. Structural changes of the vocal folds were most
noticeable in the male CF participant (Figures 3.2B and 3.2D). Upon examination, the CF
male’s left vocal fold is of the most interest. The medial aspects of the left vocal fold in
this same participant appeared as if the tissue was torn. This gave the impression of two
separate vocal folds on the left side. Additionally, there appeared to be a blister-like mass
on the posterior edge of the left vocal fold. Both of these anomalies are most evident
upon vocal fold abduction shown in Figure 3.2B.
Glottal closure seems adequate for both male participants. In the male with CF,
there appears to be a double opening due to the tear in the left vocal fold. In observing the
15

motion of the vocal folds, this tear does not significantly impact the mucosal wave or
closure of the glottis. However, the blister like mass of tissue on the posterior aspect of
the left vocal fold seemed to be a slight barrier to achieving full glottal closure during
phonation.
The laryngeal tissue surrounding the vocal folds appears to be slightly swollen
and inflamed in the male with CF, though not to the extent observed in the female with
CF. In particular, there is a section of swollen tissue directly anterior to the subject’s right
vocal fold; it is most clearly seen in Figure 3.2B, during abduction. In Figure 3.2D, the
tissue appears to come to midline during adduction and nearly cover the posterior portion
of the right vocal fold. There is a similar anomaly on the patient’s left vocal fold that is
more clearly seen when the vocal folds are adducted (Figure 3.2D).
Finally, the videostroboscopy did not reveal any significant differences in the
movement or function of the laryngeal tissue.

The vocal fold mucosal wave was

observed to be fully functional for the male CF patient, despite having the appearance of
a double left vocal fold and subsequent double glottal opening.
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A

B

C

D

Figure 3.2 Vocal folds of male participants. Shown in abducted and adducted
position. A: Abducted vocal folds male without CF. B: Abducted vocal folds of
male with CF, notice the swollen arytenoids and structural changes. C: Adducted
vocal folds of male without CF. D: Adducted vocal folds of male with CF; note the
thickness of the vocal folds as well as incomplete glottal closure.
Aerodynamic and Quantitative Vocal Parameters
Female voice. The CF patient demonstrated differences in many of the
quantitative parameters that were measured. The female patient with CF showed a
marked decrease in the parameters of MPT, Fo, percent of jitter and RAP. Additionally,
the female CF patient showed higher numbers in the areas of S/Z ratio, shimmer, and
noise-to-harmonic ratio (NHR). The CF patient displays vocal parameters that are
considered to be outside the range of normal in nearly all that were examined. The
following vocal qualities were measured to be two standard deviations (SD) from the
mean: Fo, shimmer, and NHR. These values are displayed in a comparative layout in
Table 3.1.
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Female Norms*
Age (years)
s/z ratio

0.8-1.2

MPT
(seconds)
Fo (hertz)

20
(5)
244
(17.45)
0.633
(0.351)
0.378
(0.214)
0.176
(0.071)
2.00
(0.791)
0.112
(0.009)

Jitter%
RAP%
Shimmer dB
Shimmer%
NHR

Non-CF
Female

CF Female

23

24

0.85

1.167

26

18

295

192

0.878

0.494

0.545

0.276

0.197

0.443

2.26

4.99

0.097

0.141

Table 3.1. Female vocal parameters. Vocal parameters of female
participants compared to expected vocal norms.
*Norms reported for females age 20-30 years. Standard deviation
(SD) reported in parentheses.
Male voice. The quantitative measurements for the male patients revealed less
differences than the female measures between the CF and non-CF patients. The male
patient with CF showed a minor decrease in the parameters of MPT and Fo. The
remaining measurements were higher than the non-CF male counterpart. The most
notable differences were revealed in the amount of perturbation in the CF participant. The
CF patient’s measured shimmer values are more than three SD from the mean. Exact
values for each of these vocal attribute are displayed in a comparative layout in Table 3.2.
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Male Norms *

Non-CF
Male

CF Male

Age (years)

20-30

26

29

s/z ratio

0.8-1.3

0.956

0.933

MPT
(seconds)
Fo (hertz)

30
(5)
145
(23.406)
0.59
(0.535)
0.345
(0.333)
0.219
(0.085)
2.52
(0.997)
0.122
(0.014)

38

26

121

111

0.223

1.61

0.108

0.969

0.217

0.86

2.588

10.01

0.098

0.143

Jitter%
RAP%
Shimmer dB
Shimmer%
NHR

Table 3.2. Male vocal parameters. Vocal parameters of male
participants compared to expected vocal norms.
* Norms reported for males age 20-30 years. Standard deviation (SD)
reported in parentheses.
Perceptual Self-assessment of Voice
Upon review of each person’s self-assessment, no significant factors stand out.
The two CF patients perceived themselves to have some qualities that they did not
consider to be “normal.” Perceptually, the female participant rated the following qualities
to exist mildly (rating of 1): hoarseness, huskiness, and low pitch. She rated moderate (2)
in the restricted pitch quality. In addition, she rated herself to have phonation breaks as
well as fluctuations in overall vocal quality. Her overall perceptual rating of vocal quality
was a 1, meaning mildly out of normal.
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The male participant perceived his voice as being relatively normal. He gave a
mild rating of 1 in the areas of high pitch and fast rate. A moderate rating was also given
in the category labeled “too loud.” Overall, he rated a zero, meaning he perceived himself
as having a relatively normal voice.
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CHAPTER IV
DISCUSSION
Our results show that individuals living with CF have some significant differences
in both laryngeal structures, as well as quantitative vocal parameters. To our knowledge,
this area of research has not yet been explored in detail within the United States, therefore
allowing for this purely descriptive study. The descriptions given are highly suggestive of
possible dysphonia in CF patients, and help lay the groundwork for further studies to be
conducted.
In the objective measures, a significant difference is noted when comparing the
CF patients to those without CF in the measurement of MPT. Lower MPT is typically
indicative of a compromised respiratory system, meaning there is not enough breath
support for the individual to sustain voice for the expected length of time (Boone et al.,
2014). Given the nature of cystic fibrosis and the severe adverse effects it has upon an
individual’s lung function, a decrease in MPT is not surprising. However, even while the
CF patients experience a lower MPT than the non-CF, the times of 18 and 26 seconds
still fall within average range for females and males, respectively.
The second notable difference is seen in the Fo of the female patient with CF
when compared to her non-CF counterpart, as well as the expected Fo for females. The
subject presented with a Fo of 192 Hz, 52 Hz below that of the expected 244 Hz. A
decreased fundamental frequency perceptually correlates to a low pitch when the
individual is speaking. As mentioned previously, the Fo is the number of vibratory cycles
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completed in one second during phonation. The lower the number of cycles, the lower the
person’s pitch will be. A low habitual pitch is symptomatic of the vocal folds’ inability to
move properly. Slowed movements are caused by decreased pliability, or vocal fold
stiffness.
Stiffness in the laryngeal tissue could be caused by many things, including vocal
fold scarring, which is caused by phonotrauma, or vocal abuse, and is typically indicative
of possible reduction in pitch range and a decrease in vocal fold elasticity. In the case of a
patient with CF, we would expect to see some vocal stiffness due to the excessive chronic
coughing. In addition, inhaled medications could cause dehydration of the vocal folds,
which would then result in the slowed rate of vibration and roughness upon vibration.
The last most notable variation of the acoustic measures exists when comparing
the amount of perturbation in the participants’ voices. Both the female and male CF
participants have significantly higher levels of vocal perturbation, particularly in the
amount of shimmer that exists. The male CF patient has shimmer values nearly five times
that of the expected and the female nearly twice the amount of shimmer than typically
expected. Excess amount of shimmer correlates with the perception of vocal hoarseness.
Research states that excess shimmer can have biomechanical causes. Biomechanical
etiology is a term meaning it was caused by misuse of a particular mechanism within the
body, in this case we are talking about phonotrauma to the larynx and vocal folds. Again,
given the respiratory distress, excessive coughing and possible GERD, it would be
expected that a patient with CF may have this excess amount of vocal perturbation.
In addition to the measured vocal qualities, the participants with CF showed
marked differences in their laryngeal structures and functions. These difference could
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have several different etiologies behind them. The female patient showed significant
swelling and redness in the entire laryngeal cavity, particularly in the arytenoid cartilages.
These types of changes typically result from reflux disease. The participant reported
during data collection that she had been diagnosed with GERD and only recently began
taking medication to treat it. The posterior pharyngeal wall presented in a red, bumpy
manner, and the arytenoid cartilages appeared similarly. These findings are consistent
with previous research as well as subject report. Additionally, she presented with
thickening of the vocal folds and a slowed mucosal wave. These changes are consistent
with research findings involving trauma to the laryngeal area. However, the vibratory
motion of the arytenoid cartilages is an anomaly that is rarely seen in humans and cannot,
at this time, be definitively connected to any factors related to CF.
Likewise, the male with CF had minor swelling and inflammation of the laryngeal
tissue, as well as thickening of the vocal folds. Report from this participant revealed that
he had been intubated approximately one year prior to data collection. He also reported
that he had a nasogastric (NG) tube placed following surgery. Due to these reported
complications, the presence of a posterior lesion on his left vocal fold is neither
surprising nor of major concern. It is believed that this lesion has not diminished over
time due to his bouts of excessive coughing, however, only a time-lapse trial would
definitively prove such hypotheses. The presence of a “split vocal fold” is a risk faced by
those who are intubated at some point. Due to the subject’s reported intubation and
subsequent complications, this structural change cannot be linked directly to CF at this
time.
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Additionally, research has stated that some medications can cause changes to the
vocal fold tissue. Patients with CF are typically placed on an intense treatment regimen
that often includes use of aerosolized medications to be used two or three times daily.
These medications may play a role in the tissue changes seen in the subjects of this study.
The most researched of these aerosols is hypertonic saline. While this added routine has
proven helpful for alleviating symptoms of CF, it may be creating the structural changes
seen in this study. However, given the small case study design, we cannot completely
generalize the possible cause of structural changes to the entire population of patients
with CF.
Conclusion
We have shown in this case study that individuals living with cystic fibrosis
demonstrate changes in vocal quality as well as in the laryngeal structures. The changes
seen are comparable to individuals who are considered to have a diagnosis of dysphonia.
Consistent with Lorenco et al. (2014), our findings revealed more pronounced alterations
in the female voice than in the male, with the exception of the shimmer in the male voice.
The CF-related changes to laryngeal tissue that were hypothesized in the beginning of
this study were demonstrated very clearly in the female patient. It cannot be said with any
measure of certainty, that the laryngeal and aerodynamic changes in the CF participants
are directly due to CF. Since individuals with CF are routinely on various medications for
respiratory difficulties, it may also be speculated that the changes may be directly related
to the medication rather than to the disease itself. Whatever the case, the results suggest
further investigation of the vocal parameters in individuals with CF is necessary. The
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results of this study also suggest that patients with CF may benefit, to an extent, from
voice therapy.
Limitations and Future Research
While our findings were substantial, some limitations exist that impede a
definitive conclusion. The most obvious limitation to this study was the small sample
size. Unfortunately, the ability to recruit patients with CF diminishes as the target age
increases. Many CF patients are already participating in research studies for medications
that will result in direct benefit. In order to remain in those studies, they may be
prevented from participating in any other sort of extraneous medical procedures, such as
videostroboscopy, due to the risk of exposure to infections because of an already
compromised immune system.
Future research would benefit from an increase in the number of participants.
Likewise, screening individuals before data collection in order to get a full report on
current medications would allow for a cause-effect study to take place. If a certain
medication is being used by one group, but not another, there may be further information
to gain simply from differentiating the groups taking a potentially damaging medication.
Furthermore, the wide variations that exist across patients with CF make it difficult to
confirm that abnormal voice or structural changes are a direct result for all patients. There
is always the possibility that the dysphonic qualities seen in one patient may not exist in a
second patient of the exact same age with the exact same diagnosis. This is the challenge
in conducting research within the world of medicine.
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APPENDIX A

Instructions from the investigator to the participant for measuring S/Z/ ratio:
I need you to take a breath and say “sss” for as long as you can. Next I need you to take a
breath and say “zzz” for as long as you can. We are going to complete this cycle a total of
three times. You will have time to rest between each cycle.

Instructions from the investigator to the participant for measuring MPT:
I need you to take a breath and say ‘ah’ for as long as you can. You are going to complete
this task a total of three times. You will have time to rest between each task.

Instructions from the investigator to the participant for use of the Visi-PitchTM:
You are going to stand with the microphone approximately two inches from your mouth.
When I tell you to go, you will say “ah” in your normal speaking voice until I tell you to
stop. It will only be a couple of seconds. We are going to do this twice.

Instructions from the investigator to the participant for videostroboscopy:
I am going to spray a light topical numbing spray into the back of your mouth. We will
wait approximately ten minutes for it to take affect before beginning with the scope. I
need you to relax and stick your tongue out. I will slide the scope back in your mouth
along the base of your tongue. Once the camera is where it is needed, I will ask you to
say either “ah” or “ee.”
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APPENDIX B

Effects of Cystic Fibrosis on Vocal Fold Function
Informed Consent Form
Dear Participant:
We are Dr. Violet Cox and Veronica Smitley, faculty member and graduate student,
respectively, in the Department of Speech and Hearing at Cleveland State University. We
would like you to participate in a research study. The study is about vocal fold function in
people with cystic fibrosis (CF). We will look at vocal folds during production of a vowel
sound. We will use a tiny camera and light source placed over your tongue. We hope that
this study will help to contribute to improving voice quality for people with CF.
The data collected will be confidential. Your name and other identifying
information will not be linked with the data collected. Every effort will be exerted to
maintain privacy. Results of this study will not be traced back to you.
You will be tested at the Cleveland State University Voice and Swallowing lab
located in CIM 211. We will provide you with directions to the University. Participation
in this study is voluntary. You may withdraw at any time. There is no reward for
participating, or consequence for not participating. Outside of risks associated with those
of daily living, there is a very slight possibility that you may experience gagging during
the oral examination. To reduce this gag a light numbing spray may be applied to the
back of your throat. If you are allergic to nova-caine routinely used by your dentist then
this spray will not be used. You will not have to participate in this study. This study will
take about 60 minutes to complete.
For further information regarding this research please contact Dr. Violet Cox at
(216) 687-6909, email: v.cox@csuohio.edu. If you have any questions about your rights
as a research participant you may contact the Cleveland State University Institutional
Review Board at (216)687-3630.
There are two copies of this letter. After signing them, keep one copy for your
records and return the other copy to me. I thank you in advance for your cooperation and
support. Please indicate your agreement to participate by signing below.
“I am 18 years or older and have read and understood this consent form and agree to
participate.”
Signature: ___________________________________________
Name: ___________________________________________ (Please Print)
Date: ___________________________________________
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APPENDIX C

BRIEF SCREENING TOOL

AGE_____________
GENDER: [ ] Male [ ] female

Answer all questions that follow:

1.
2.
3.
4.
5.

Have you ever been given Nova-caine by your dentist? Yes No
Are you allergic to Nova-caine? Yes No
Are you a smoker? Yes No
Do you have a history of any chronic respiratory illness? Yes No
Are you currently on medications? Yes No. If yes list all medications
below.____________________________________________________________
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
_________________________________________________
6. Are you on oxygen? Yes No. If yes, state how many liters.
________________________
7. Have you ever had a history of a voice disorder? Yes No
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